Is skin thinning a recognised adverse effect of Eumovate Cream containing clobetasone butyrate?

Yes, skin thinning (skin atrophy) is a very rare adverse effect of Eumovate Cream (clobetasone butyrate), listed as secondary to local and/or systemic effects of hypothalamic-pituitary adrenal (HPA) axis suppression.